Determining the molecular pathways underlying the protective effect of non-steroidal anti-inflammatory drugs for Alzheimer's disease: A bioinformatics approach
Alzheimer's disease (AD) represents a substantial unmet need, due to increasing prevalence in an ageing society and the absence of a disease modifying therapy. Epidemiological evidence shows a protective effect of non steroidal anti inflammatory (NSAID) drugs, and genome wide association studie...
Main Authors: | Nevado-Holgado, A, Lovestone, S |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2016
|
Similar Items
-
Determining the Molecular Pathways Underlying the Protective Effect of Non-Steroidal Anti-Inflammatory Drugs for Alzheimer's Disease: A Bioinformatics Approach
by: Alejo J Nevado-Holgado, et al.
Published: (2017-01-01) -
Red blood cell indices and anaemia as causative factors for cognitive function deficits and for Alzheimer's disease
by: Winchester, L, et al.
Published: (2018) -
Non-Steroidal Anti-Inflammatory Drugs in Alzheimer's Disease and Parkinson's Disease: Reconsidering the Role of Neuroinflammation
by: Amy H. Moore, et al.
Published: (2010-06-01) -
Non-steroidal anti-inflammatory drugs use in older adults decreases risk of Alzheimer's disease mortality.
by: Julián Benito-León, et al.
Published: (2019-01-01) -
The influence of insulin resistance on CSF and plasma biomarkers of Alzheimer’s pathology
by: Westwood, S, et al.
Published: (2017)